GlassScriptPhysician profile
Kimberly S Smith
NPI 1003924861
$2,036.62
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $1,085 · 2021: $268 · 2022: $212 · 2023: $183 · 2024: $33.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $217.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $1,173.48 | 2019-2023 | Na, Motoband |
| Zimmer Biomet Holdings, INC. | $484.26 | 2019-2023 | Stanmore Revision Knee, Oss Orthopedic Salvage System, Comprehensive Shoulder System |
| Orthalign INC | $113.48 | 2022 | |
| Medical Device Business Services, INC. | $94.46 | 2020 | |
| Acera Surgical, INC. | $35.72 | 2022-2024 | Restrata Wound Matrix |
| Innovation Technologies INC | $34.44 | 2023 | Irrisept |
| Convatec INC. | $23.27 | 2023 | |
| Onkos Surgical, INC. | $21.63 | 2021 | |
| Kci USA, INC. | $20.61 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $18.91 | 2023 | Seglentis |
| Amgen INC. | $16.36 | 2024 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.